| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1053-2498(01)00289-3 |
| P698 | PubMed publication ID | 11557189 |
| P2093 | author name string | Kassner A | |
| Brinkmann T | |||
| Kleesiek K | |||
| Körfer R | |||
| Thieleczek R | |||
| Arusoglu L | |||
| Fey O | |||
| Sarnowski P | |||
| Milting H | |||
| EL Banayosy A | |||
| P2860 | cites work | Natriuretic peptide system in human heart failure | Q28261612 |
| Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism | Q33902374 | ||
| Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide | Q34184637 | ||
| Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy--first results of the Halle Assist Induced Recovery Study (HAIR). | Q38325425 | ||
| Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. | Q41681221 | ||
| Integrin dependence of brain natriuretic peptide gene promoter activation by mechanical strain | Q41730133 | ||
| Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. | Q44835977 | ||
| Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure | Q48093809 | ||
| Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure | Q48340103 | ||
| Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy | Q48853320 | ||
| Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery | Q63984849 | ||
| Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation | Q68434591 | ||
| Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor | Q70044729 | ||
| Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure | Q71079840 | ||
| Mechanical circulatory support: the Bad Oeynhausen experience | Q72494462 | ||
| Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome | Q73513246 | ||
| Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy | Q73558482 | ||
| Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure | Q74696316 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 949-955 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | The Journal of Heart and Lung Transplantation | Q2364382 |
| P1476 | title | The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types | |
| P478 | volume | 20 |
| Q36496035 | Adipose tissue biology and cardiomyopathy: translational implications |
| Q38249997 | Biomarkers in mechanical circulatory support |
| Q44636614 | Differential regulation of Ca2+-dependent ATPase-activity in left ventricular myocardium during mechanical circulatory support |
| Q64267151 | Dynamics and prognostic value of B-type natriuretic peptide in left ventricular assist device recipients |
| Q33645107 | Left ventricular remodeling and myocardial recovery on mechanical circulatory support |
| Q62476321 | Myocardial Recovery With Left Ventricular Assist Devices |
| Q37894731 | Novel biomarkers in human terminal heart failure and under mechanical circulatory support |
| Q41029983 | Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients |
| Q51183535 | Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. |
| Q30487874 | Serum Brain Natriuretic Peptide Concentration 60 Days after Surgery as a Predictor of Long-term Prognosis in Patients Implanted with a Left Ventricular Assist Device |
| Q89414809 | The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery |
| Q40251545 | The influence of operational protocol on the fluid dynamics in the 12 cc Penn state pulsatile pediatric ventricular assist device: the effect of end-diastolic delay. |
| Q44829171 | The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling |
Search more.